NCT06753526View on ClinicalTrials.gov

L-Arginine Role for Stone Lower Ureter : A Randomized Control Study

PHASE4CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

June 30, 2024

Conditions
Stone Lower Ureter
Interventions
DRUG

NSAID

For 1st group of patients

DRUG

L-Arginine, 500 Mg Oral Capsule

group 2by twice dose

DRUG

Tamsulosin 0.4 mg QD

group 3 by once per day

Trial Locations (1)

82511

Faculty of medicine, Sohag University, Sohag

All Listed Sponsors
lead

Sohag University

OTHER

NCT06753526 - L-Arginine Role for Stone Lower Ureter : A Randomized Control Study | Biotech Hunter | Biotech Hunter